Drugs Made In America Acquisition Corp. (DMAAR)
Market Open
12 Jun, 13:30
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 11
+0.01
+9.7%
$
353.86M Market Cap
- P/E Ratio
- Div Yield
31,652 Volume
- Eps
$ 0.1
Previous Close Investors:
Want to track DMAAR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. (DMAAR) Statistics
Valuation metrics
Market Cap 353.86M
Enterprise value 357.82M
Trailing P/E (ttm) 36.66
Forward P/E -
PEG ratio -0.37
Price/Sales (ttm) -
Price/Book (mrq) 1.04
Enterprise Value/Revenue -
Enterprise Value/EBITDA -136.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.66K
Average volume (90 days) 130.07K
Price summary
52-Week low 0.09
52-Week high 0.11
Beta -
50-Day moving average 0.11
200-Day moving average 0.12
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.03%
Book value per share (mrq) 10.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
